In-vivo purging of the circulating clonal T-cells with Alemtuzumab prior to autologous peripheral blood hematopoietic cell mobilization and transplantation

Br J Haematol. 2011 Aug;154(3):415-8. doi: 10.1111/j.1365-2141.2011.08619.x. Epub 2011 Apr 13.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Alemtuzumab
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Bone Marrow Purging / methods*
  • Drug Evaluation / methods
  • Feasibility Studies
  • Female
  • Hematopoietic Stem Cell Mobilization / methods
  • Humans
  • Lymphoma, T-Cell, Peripheral / therapy*
  • Peripheral Blood Stem Cell Transplantation / methods*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm
  • Antineoplastic Agents
  • Alemtuzumab